Other languages MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Delayed Canadian Securities Exchange Other stock markets 09:30:00 2024-04-22 am EDT			5-day change	1st Jan Change
0.03 ^CAD	0.00%		0.00%	-25.00%

Mar. 21	MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI
Mar. 04	MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 20
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Mar. 04
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director	Jan. 30
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO	Dec. 06
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman	Dec. 06
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer	Dec. 06
MYND Life Sciences Inc. Appoints John Campbell as President	Dec. 06
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-19
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-05-05
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	23-04-27
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-04-27
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-27
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	22-06-28
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-23
MYND Life Sciences Inc. Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins	22-06-01
MYND Lifesciencs Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	22-03-31
MYND Lifesciencs Inc. Hires Chaahat S.B Singh as Senior Operations and Research Manager	22-03-09
MYND Lifesciencs Inc. Auditor Raises 'Going Concern' Doubt	22-02-27
MYND Lifesciencs Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	22-02-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Other languages

Filters